BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 27438349)

  • 1. Protein bio-corona: critical issue in immune nanotoxicology.
    Neagu M; Piperigkou Z; Karamanou K; Engin AB; Docea AO; Constantin C; Negrei C; Nikitovic D; Tsatsakis A
    Arch Toxicol; 2017 Mar; 91(3):1031-1048. PubMed ID: 27438349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The concept of bio-corona in modulating the toxicity of engineered nanomaterials (ENM).
    Westmeier D; Stauber RH; Docter D
    Toxicol Appl Pharmacol; 2016 May; 299():53-7. PubMed ID: 26592323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the immunological interactions of engineered nanomaterials: Role of the bio-corona.
    Fadeel B
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Nov; 14(6):e1798. PubMed ID: 36416023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
    Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
    Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of the Protein Corona: The Interface between Nanoparticles and the Immune System.
    Barbero F; Russo L; Vitali M; Piella J; Salvo I; Borrajo ML; Busquets-Fité M; Grandori R; Bastús NG; Casals E; Puntes V
    Semin Immunol; 2017 Dec; 34():52-60. PubMed ID: 29066063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein Nanoparticle Charge and Hydrophobicity Govern Protein Corona and Macrophage Uptake.
    Pustulka SM; Ling K; Pish SL; Champion JA
    ACS Appl Mater Interfaces; 2020 Oct; 12(43):48284-48295. PubMed ID: 33054178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bio- and eco-corona related to plants: Understanding the formation and biological effects of plant protein coatings on nanoparticles.
    Yu Y; Dai W; Luan Y
    Environ Pollut; 2023 Jan; 317():120784. PubMed ID: 36462678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of surface chemistry and morphology of nanoparticles on protein corona formation.
    Bilardo R; Traldi F; Vdovchenko A; Resmini M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jul; 14(4):e1788. PubMed ID: 35257495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How protein coronas determine the fate of engineered nanoparticles in biological environment.
    Capjak I; Goreta SŠ; Jurašin DD; Vrček IV
    Arh Hig Rada Toksikol; 2017 Dec; 68(4):245-253. PubMed ID: 29337683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the protein corona on nanomaterial immune response and targeting ability.
    Digiacomo L; Pozzi D; Palchetti S; Zingoni A; Caracciolo G
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jul; 12(4):e1615. PubMed ID: 32003104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the bionano interface and mapping extrinsic interactions of the corona of nanomaterials.
    O'Connell DJ; Bombelli FB; Pitek AS; Monopoli MP; Cahill DJ; Dawson KA
    Nanoscale; 2015 Oct; 7(37):15268-76. PubMed ID: 26324751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Crown and the Scepter: Roles of the Protein Corona in Nanomedicine.
    Cai R; Chen C
    Adv Mater; 2019 Nov; 31(45):e1805740. PubMed ID: 30589115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An In Situ Investigation of the Protein Corona Formation Kinetics of Single Nanomedicine Carriers by Self-Regulated Electrochemiluminescence Microscopy.
    Xing Z; Gou X; Jiang LP; Zhu JJ; Ma C
    Angew Chem Int Ed Engl; 2023 Sep; 62(39):e202308950. PubMed ID: 37553293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein corona, understanding the nanoparticle-protein interactions and future perspectives: A critical review.
    Kopac T
    Int J Biol Macromol; 2021 Feb; 169():290-301. PubMed ID: 33340622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No king without a crown--impact of the nanomaterial-protein corona on nanobiomedicine.
    Docter D; Strieth S; Westmeier D; Hayden O; Gao M; Knauer SK; Stauber RH
    Nanomedicine (Lond); 2015 Feb; 10(3):503-19. PubMed ID: 25707981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biomolecular corona of nanomedicines: effects on nanomedicine outcomes and emerging opportunities.
    Salvati A
    Curr Opin Biotechnol; 2024 Jun; 87():103101. PubMed ID: 38461749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploiting the novel properties of protein coronas: emerging applications in nanomedicine.
    Hamad-Schifferli K
    Nanomedicine (Lond); 2015 May; 10(10):1663-74. PubMed ID: 26008198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticle-allergen interactions mediate human allergic responses: protein corona characterization and cellular responses.
    Radauer-Preiml I; Andosch A; Hawranek T; Luetz-Meindl U; Wiederstein M; Horejs-Hoeck J; Himly M; Boyles M; Duschl A
    Part Fibre Toxicol; 2016 Jan; 13():3. PubMed ID: 26772182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation and Characterization of Protein Corona Around Nanoparticles: A Review.
    Pareek V; Bhargava A; Bhanot V; Gupta R; Jain N; Panwar J
    J Nanosci Nanotechnol; 2018 Oct; 18(10):6653-6670. PubMed ID: 29954482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro in-vivo correlation (IVIVC) in nanomedicine: Is protein corona the missing link?
    Jain P; Pawar RS; Pandey RS; Madan J; Pawar S; Lakshmi PK; Sudheesh MS
    Biotechnol Adv; 2017 Nov; 35(7):889-904. PubMed ID: 28844973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.